421 related articles for article (PubMed ID: 21281822)
1. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
Lin SL; Chang FC; Schrimpf C; Chen YT; Wu CF; Wu VC; Chiang WC; Kuhnert F; Kuo CJ; Chen YM; Wu KD; Tsai TJ; Duffield JS
Am J Pathol; 2011 Feb; 178(2):911-23. PubMed ID: 21281822
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
3. The role played by perivascular cells in kidney interstitial injury.
Rojas A; Chang FC; Lin SL; Duffield JS
Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of fibrosis: the role of the pericyte.
Schrimpf C; Duffield JS
Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
[TBL] [Abstract][Full Text] [Related]
5. Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma.
Ye X; Abou-Rayyah Y; Bischoff J; Ritchie A; Sebire NJ; Watts P; Churchill AJ; Bates DO
J Pathol; 2016 Jun; 239(2):139-51. PubMed ID: 26957058
[TBL] [Abstract][Full Text] [Related]
6. Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes.
Wang M; Xu H; Li Y; Cao C; Zhu H; Wang Y; Zhao Z; Pei G; Zhu F; Yang Q; Deng X; Zhou C; Guo Y; Wu J; Liao W; Yang J; Yao Y; Zeng R
Theranostics; 2020; 10(26):12144-12157. PubMed ID: 33204334
[No Abstract] [Full Text] [Related]
7. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
[TBL] [Abstract][Full Text] [Related]
8. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.
Kida Y; Ieronimakis N; Schrimpf C; Reyes M; Duffield JS
J Am Soc Nephrol; 2013 Mar; 24(4):559-72. PubMed ID: 23492730
[TBL] [Abstract][Full Text] [Related]
9. Kidney pericytes: a novel therapeutic target in interstitial fibrosis.
Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS
Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
[TBL] [Abstract][Full Text] [Related]
11. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation.
Kida Y; Zullo JA; Goligorsky MS
Biochem Biophys Res Commun; 2016 Sep; 478(3):1074-9. PubMed ID: 27524235
[TBL] [Abstract][Full Text] [Related]
12. Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.
Darden J; Payne LB; Zhao H; Chappell JC
Angiogenesis; 2019 Feb; 22(1):167-183. PubMed ID: 30238211
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of capillary VEGF isoforms following traumatic brain injury.
Dore-Duffy P; Wang X; Mehedi A; Kreipke CW; Rafols JA
Neurol Res; 2007 Jun; 29(4):395-403. PubMed ID: 17626736
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-107 antagonizes profibrotic phenotypes of pericytes by targeting a pathway involving HIF-1
Wang YC; Xie H; Zhang YC; Meng QH; Xiong MM; Jia MW; Peng F; Tang DL
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H520-H534. PubMed ID: 33216617
[TBL] [Abstract][Full Text] [Related]
15. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro.
Magnusson PU; Looman C; Ahgren A; Wu Y; Claesson-Welsh L; Heuchel RL
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2142-9. PubMed ID: 17656670
[TBL] [Abstract][Full Text] [Related]
17. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
18. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of vascular integrity by pericytes is essential for normal kidney function.
Lemos DR; Marsh G; Huang A; Campanholle G; Aburatani T; Dang L; Gomez I; Fisher K; Ligresti G; Peti-Peterdi J; Duffield JS
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1230-F1242. PubMed ID: 27335372
[TBL] [Abstract][Full Text] [Related]
20. Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy.
Humphreys BD
Semin Nephrol; 2012 Sep; 32(5):463-70. PubMed ID: 23062987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
